CHRONIC SPONTANEOUS URTICARIA (CSU)
Clinical trials for CHRONIC SPONTANEOUS URTICARIA (CSU) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC SPONTANEOUS URTICARIA (CSU) trials appear
Sign up with your email to follow new studies for CHRONIC SPONTANEOUS URTICARIA (CSU), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a cheaper version of a biologic drug keep Patients' symptoms under control?
Disease control Recruiting nowThis study is observing patients who are already doing well on a specific biologic drug (omalizumab) for severe asthma or chronic hives. Their doctors have decided to switch them to a similar, lower-cost version called a biosimilar. The main goal is to see if patients remain stab…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Sponsor: Celltrion HealthCare France • Aim: Disease control
Last updated Apr 03, 2026 21:26 UTC
-
Race for faster hives relief: new pill takes on established shot
Disease control Recruiting nowThis study is testing if a new oral medication called remibrutinib works faster than an existing injectable drug, dupilumab, to control chronic hives. It will involve about 400 US adults whose hives and itching are not controlled by standard allergy pills. Participants will take …
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists investigate hidden clues in allergy antibodies
Knowledge-focused Recruiting nowThis study aims to understand how different versions of an allergy-related antibody (IgE) are connected to various allergic conditions. Researchers will observe 200 adult participants, including people with allergies like anaphylaxis, chronic hives, and venom allergies, as well a…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Sponsor: KU Leuven • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC